Rosetta Genomics Ltd. Income (Loss) from Continuing Operations, Per Basic and Diluted Share
Rosetta Genomics Ltd. reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of $0.45 per share for the 3-month period ending 2017-06-30, per its 6-K filed 2017-10-10.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2017-10-10
- Rosetta Genomics Ltd. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2017-06-30 was $0.45, a 75.94% decline year-over-year.
- Rosetta Genomics Ltd. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2016-06-30 was $1.87.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month as first filed |
|---|---|---|---|---|
| 2017-06-30 | $0.45 6-K · filed 2017-10-10 | $1.31 6-K · filed 2017-10-10 | ||
| 2016-12-31 | $7.15 6-K · filed 2017-10-10 | |||
| 2016-06-30 | $1.87 6-K · filed 2017-10-10 | $3.82 6-K · filed 2017-10-10 | ||
| 2015-12-31 | $11.57 6-K · filed 2017-10-10 | -$1.15 20-F · filed 2016-03-23 | ||
| 2014-12-31 | $15.51 6-K · filed 2017-10-10 | -$1.29 20-F · filed 2015-03-16 | ||
| 2014-06-30 | $0.66 6-K · filed 2014-09-17 | |||
| 2013-12-31 | -$1.37 6-K · filed 2016-12-08 | |||
| 2013-06-30 | $0.71 6-K · filed 2014-09-17 | |||
| 2012-12-31 | -$2.40 20-F · filed 2015-03-16 | |||
| 2012-06-30 | -$5.35 6-K · filed 2012-09-28 | |||
| 2011-12-31 | -$14.55 20-F · filed 2014-03-31 | $0.97 20-F/A · filed 2012-05-01 | ||
| 2011-06-30 | -$8.34 6-K · filed 2012-09-28 | |||
| 2010-12-31 | -$45.75 20-F · filed 2013-03-22 | $3.05 20-F/A · filed 2012-05-01 | ||
| 2009-12-31 | $65.40 6-K · filed 2012-12-07 | $4.36 20-F/A · filed 2012-05-01 |